Establishment and characterization of a cell line (DEOC-1) originating from a human malignant melanoma of the skin

Human Cell

Volumn 20, Issue 2, 2007, Pages 23-38

  Maeshima, Seiji ^a   Yamada, Takashi ^a   Kiyokane, Kimihiro ^a   Mori, Hiroshi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

5 S cysteinyldopa; Cell line; Human; Malignant melanoma; Multidrug resistance related gene

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYSTEINYLDOPA; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; LUNG RESISTANCE PROTEIN; MESSENGER RNA; METHOTREXATE; MITOMYCIN C; NIMUSTINE; PEPLEOMYCIN; TAMOXIFEN CITRATE; VINBLASTINE; VINCRISTINE;

ADULT; ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IN VITRO SELECTION; MALE; MELANOMA; PRIORITY JOURNAL; SPINDLE CELL; SUBCUTANEOUS TISSUE; SURGICAL TECHNIQUE;

ANIMALS; CELL LINE, TUMOR; CYSTEINYLDOPA; DRUG RESISTANCE, MULTIPLE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MICE; MICE, SCID; MIDDLE AGED; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 34249800093     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2007.00028.x     Document Type: Article

References (39)

1. Wakamatsu K, Ito S. Improved HPLC determination of 5-S-cysteinyldopa in serum. Clin Chem 1994 40 : 495 6.
2. Twentyman PR, Luscombe M. A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. Br J Cancer 1987 56 : 279 85.
3. Papanicolaou GN. A new procedure for staining vaginal smears. Science 1942 95 : 438 9.
4. Masuda H, Fujihira S, Ueno H, Kagawa M, Katsuoka Y, Mori H. Ultrastructural study on cytotoxic effects of cyclosporine A in spermiogenesis in rats. Med Electron Microsc 2003 36 : 183 91.
5. Yamada T, Ueda M, Otsuki Y, Ueki M, Sugimoto O. Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary. Gynecol Oncol 1991 40 : 118 28.
6. Ito S, Wakamatsu K, Ozeki H. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis. Pigment Cell Res 2000 13 (Suppl. 8 103 9.
7. Tattersall MH, Sodergren JE, Dengupta SK, Trites DH, Modest EJ, Frei E III. Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther 1975 17 : 701 8.
8. Mori T, Mineura K, Katakura R. [A consideration on pharmacokinetics of a new water-soluble anti-tumor nitrosourea, ACNU, in patients with malignant brain tumor (author's translation)]. No To Shinkei 1979 31 : 601 6.
9. Benjamin RS. Pharmacokinetics of adriamycin (NSC-123127) in patients with sarcomas. Cancer Chemother Rep 1974 58 : 271 3.
10. Fujita H. [Studies on concentration of bleomycin in blood, urine and tissues (author's translation)]. Chemotherapy 1969 17 : 933 7.
11. Imai Y, Nakamura K, Watanabe S, Tamura K, Takada K. [Clinical studies of malignant tumors in the oral and maxillofacial region: Time course of blood concentration of pepleomycin in the cases treated with pepleomycin sulfate (a bleomycin derivative) (author's translation)]. Jap J Cancer Clin 1980 26 : 333 6.
12. Elferink F, van der Vijgh WJ, Klein I, Vermorken JB, Gall HE, Pinedo HM. Pharmacokinetics of carboplatin after i.v. administration. Cancer Treat Rep 1987 71 : 1231 7.
13. Vermorken JB, van der Vijgh WJ, Klein I, Gall HE, Pinedo HM. Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications. Eur J Cancer Clin Oncol 1982 18 : 1069 74.
14. Stewart DJ, Nundy D, Maroun JA, Tetreault L, Prior J. Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide. Cancer Treat Rep 1985 69 : 269 73.
15. Tchekmedyian NS, Egorin MJ, Cohen BE, Kaplan RS, Poplin E, Aisner J. Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion. Cancer Chemother Pharmacol 1986 18 : 33 8.
16. Nelson RL. The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer. Med Pediatr Oncol 1982 10 : 115 27.
17. Breithaupt H, Dammann A, Aigner K. Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Cancer Chemother Pharmacol 1982 9 : 103 9.
18. Kikuchi K, Kanno H. [Comparison for blood levels and clinical effects between tablet and other dosage forms of 5-fluorouracil (author's translation)]. Gan To Kagaku Ryoho 1979 6 : 559 65.
19. Fujita H. [Pharmacokinetics of mitomycin C and its derivative (KW-2083) (author's translation)]. Gan To Kagaku Ryoho 1982 9 : 1362 73.
20. Campbell MA, Perrier DG, Dorr RT, Alberts DS, Finley PR. Methotrexate: bioavailability and pharmacokinetics. Cancer Treat Rep 1985 69 : 833 8.
21. Molino A, Stevanoni G, Lorenzi P et al. Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties. Tumori 1988 74 : 151 5.
22. Rauth S, Kichina J, Green A, Bratescu L, Das Gupta TK. Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasizing in nude mice. Anticancer Res 1994 14 : 2457 63.
23. Enjoji M, Nakashima M, Sakai H, Nawata H. Establishment of a melanoma cell line with metastatic characteristics. Hum Cell 1995 8 : 115 20.
24. Nozawa S, Ohta H, Tsukazaki K, Udagawa Y, Kurihara S, Kano S. [A newly established melanoma cell line (GAK) with 5-S-cysteinyldopa phenotype (author's translation)]. Nippon Sanka Fujinka Gakkai Zasshi 1984 36 : 883 92.
25. Kiguchi K, Ishiwata I, Ishiwata C et al. Establishment and characterization of melanoma cell line derived from malignant melanoma of human uterine cervix. Hum Cell 1998 11 : 93 100.
26. Yoshikawa F, Sakuda M. Production of self-migration stimulating factor by metastatic human malignant melanoma cells established in culture. Res Commun Chem Pathol Pharmacol 1991 73 : 21 9.
27. Tagawa T, Yatani R, Nishioka H, Murata M. Primary malignant melanoma of the oral cavity. Case report and establishment of melanoma cell line. Int J Oral Surg 1981 10 (Suppl. 1 16 20.
28. Chang KW, Lin SC, Chao SY, Kwan PC, Chiu CP, Wong YK. Establishment and characterization of an oral melanoma cell line (ME). Oral Oncol 2001 37 : 301 7.
29. De Waard-Siebinga I, Blom DJ, Griffioen M et al. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 1995 62 : 155 61.
30. Luyten GP, Naus NC, Mooy CM et al. Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int J Cancer 1996 66 : 380 7.
31. Diebold Y, Blanco G, Saornil MA, Fernandez N, Lazaro MC. Morphologic and immunocytochemical characterization of four human uveal cell lines (melanoma- and melanocytes-derived). Curr Eye Res 1997 16 : 487 95.
32. Hiraga H, Nojima T, Abe S et al. Establishment of a new continuous clear cell sarcoma cell line. Morphological and cytogenetic characterization and detection of chimaeric EWS/ATF-1 transcripts. Virchows Arch 1997 431 : 45 51.
33. Takenouchi T, Ito K, Kazama T, Ito M. Establishment and characterization of a clear-cell sarcoma (malignant melanoma of soft parts) cell line. Arch Dermatol Res 1994 286 : 254 60.
34. Nagashima Y, Miyagi Y, Yu K et al. Establishment of three rat soft tissue tumor cell lines with different degrees of myogenic differentiation. Pathol Res Pract 1994 190 : 1071 6.
35. Carey WD, Prunieras M. An improved method for the establishment of cell lines from primary skin melanomas. Br J Dermatol 1984 110 : 265 71.
36. Albert DM, Ruzzo MA, McLaughlin MA, Robinson NL, Craft JL, Epstein J. Establishment of cell lines of uveal melanoma. Methodology and characteristics. Invest Ophthalmol Vis Sci 1984 25 : 1284 99.
37. Wakamatsu K, Kageshita T, Furue M et al. Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 years' experience. Melanoma Res 2002 12 : 245 53.
38. McCormick D, Wallace I, Kirk J, Dinsmore S, Allen I. The establishment and characterization of a cell line and mouse xenografts from a human malignant melanoma. Br J Exp Pathol 1983 64 : 103 15.
39. Kong CZ, Zeng Y, Wu XX, Li JQ, Zhu YY, Chen Y. Increased expression of lung resistance-related protein in lower grade urothelial carcinoma of the renal pelvis and ureter. Int J Urol 2004 11 : 721 7.